• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑制巨噬细胞增殖在胆固醇降低引起的斑块消退中起主导作用。

Inhibition of macrophage proliferation dominates plaque regression in response to cholesterol lowering.

机构信息

Department of Cardiology and Angiology I, University Heart Center Freiburg-Bad Krozingen and Faculty of Medicine, University of Freiburg, 55 Hugstetter St, 79106, Freiburg, Germany.

Institute for Experimental Cardiovascular Medicine, University Heart Center Freiburg-Bad Krozingen and Faculty of Medicine, University of Freiburg, Freiburg, Germany.

出版信息

Basic Res Cardiol. 2020 Dec 9;115(6):78. doi: 10.1007/s00395-020-00838-4.

DOI:10.1007/s00395-020-00838-4
PMID:33296022
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7725697/
Abstract

Statins induce plaque regression characterized by reduced macrophage content in humans, but the underlying mechanisms remain speculative. Studying the translational APOE*3-Leiden.CETP mouse model with a humanized lipoprotein metabolism, we find that systemic cholesterol lowering by oral atorvastatin or dietary restriction inhibits monocyte infiltration, and reverses macrophage accumulation in atherosclerotic plaques. Contrary to current believes, none of (1) reduced monocyte influx (studied by cell fate mapping in thorax-shielded irradiation bone marrow chimeras), (2) enhanced macrophage egress (studied by fluorescent bead labeling and transfer), or (3) atorvastatin accumulation in murine or human plaque (assessed by mass spectrometry) could adequately account for the observed loss in macrophage content in plaques that undergo phenotypic regression. Instead, suppression of local proliferation of macrophages dominates phenotypic plaque regression in response to cholesterol lowering: the lower the levels of serum LDL-cholesterol and lipid contents in murine aortic and human carotid artery plaques, the lower the rates of in situ macrophage proliferation. Our study identifies macrophage proliferation as the predominant turnover determinant and an attractive target for inducing plaque regression.

摘要

他汀类药物可诱导斑块消退,其特征是人类巨噬细胞含量减少,但潜在机制仍在推测之中。通过研究具有人源化脂蛋白代谢的翻译 APOE*3-Leiden.CETP 小鼠模型,我们发现口服阿托伐他汀或饮食限制降低全身胆固醇可抑制单核细胞浸润,并逆转动脉粥样硬化斑块中巨噬细胞的积累。与目前的观点相反,(1)减少单核细胞浸润(通过胸屏蔽照射骨髓嵌合体中的细胞命运图谱研究),(2)增强巨噬细胞迁出(通过荧光珠标记和转移研究),或(3)阿托伐他汀在鼠或人斑块中的积累(通过质谱法评估)均不能充分解释在经历表型消退的斑块中观察到的巨噬细胞含量的减少。相反,抑制局部巨噬细胞增殖在对胆固醇降低的反应中占主导地位:血清 LDL-胆固醇和鼠主动脉及人颈动脉斑块中脂质含量越低,原位巨噬细胞增殖率越低。我们的研究确定了巨噬细胞增殖是主要的更替决定因素,并为诱导斑块消退提供了有吸引力的靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6843/7725697/9f8b1f9b817f/395_2020_838_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6843/7725697/bdda69b4a47c/395_2020_838_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6843/7725697/adb2a460de37/395_2020_838_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6843/7725697/09be1ed77d3e/395_2020_838_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6843/7725697/4eea34429816/395_2020_838_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6843/7725697/a86e14b1a9f0/395_2020_838_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6843/7725697/f6dc3a75e246/395_2020_838_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6843/7725697/9f8b1f9b817f/395_2020_838_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6843/7725697/bdda69b4a47c/395_2020_838_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6843/7725697/adb2a460de37/395_2020_838_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6843/7725697/09be1ed77d3e/395_2020_838_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6843/7725697/4eea34429816/395_2020_838_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6843/7725697/a86e14b1a9f0/395_2020_838_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6843/7725697/f6dc3a75e246/395_2020_838_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6843/7725697/9f8b1f9b817f/395_2020_838_Fig7_HTML.jpg

相似文献

1
Inhibition of macrophage proliferation dominates plaque regression in response to cholesterol lowering.抑制巨噬细胞增殖在胆固醇降低引起的斑块消退中起主导作用。
Basic Res Cardiol. 2020 Dec 9;115(6):78. doi: 10.1007/s00395-020-00838-4.
2
Rosuvastatin Reduces Aortic Sinus and Coronary Artery Atherosclerosis in SR-B1 (Scavenger Receptor Class B Type 1)/ApoE (Apolipoprotein E) Double Knockout Mice Independently of Plasma Cholesterol Lowering.瑞舒伐他汀独立于降低血浆胆固醇水平减少载脂蛋白 E/清道夫受体 B1 双重基因敲除小鼠主动脉窦和冠状动脉粥样硬化
Arterioscler Thromb Vasc Biol. 2018 Jan;38(1):26-39. doi: 10.1161/ATVBAHA.117.305140. Epub 2017 Nov 21.
3
In vivo fluorescence-mediated tomography imaging demonstrates atorvastatin-mediated reduction of lesion macrophages in ApoE-/- mice.体内荧光介导断层成像显示阿托伐他汀可减少 ApoE-/- 小鼠的病变巨噬细胞。
Anesthesiology. 2013 Jul;119(1):129-41. doi: 10.1097/ALN.0b013e318291c18b.
4
Apolipoprotein AI) Promotes Atherosclerosis Regression in Diabetic Mice by Suppressing Myelopoiesis and Plaque Inflammation.载脂蛋白 AI 通过抑制骨髓生成和斑块炎症促进糖尿病小鼠的动脉粥样硬化消退。
Circulation. 2019 Oct;140(14):1170-1184. doi: 10.1161/CIRCULATIONAHA.119.039476. Epub 2019 Sep 30.
5
Resveratrol protects against atherosclerosis, but does not add to the antiatherogenic effect of atorvastatin, in APOE*3-Leiden.CETP mice.白藜芦醇可预防动脉粥样硬化,但不能增强 APOE*3-Leiden.CETP 小鼠阿托伐他汀的抗动脉粥样硬化作用。
J Nutr Biochem. 2013 Aug;24(8):1423-30. doi: 10.1016/j.jnutbio.2012.11.009. Epub 2013 Jan 18.
6
Atorvastatin increases HDL cholesterol by reducing CETP expression in cholesterol-fed APOE*3-Leiden.CETP mice.阿托伐他汀通过降低高胆固醇喂养的载脂蛋白E*3-莱顿.CETP小鼠中的CETP表达来增加高密度脂蛋白胆固醇。
Atherosclerosis. 2008 Mar;197(1):57-63. doi: 10.1016/j.atherosclerosis.2007.08.001. Epub 2007 Sep 14.
7
Effects of atorvastatin and diet interventions on atherosclerotic plaque inflammation and [F]FDG uptake in LdlrApob mice.阿托伐他汀和饮食干预对 LDLRAPOB 小鼠动脉粥样硬化斑块炎症和 [F]FDG 摄取的影响。
Atherosclerosis. 2017 Aug;263:369-376. doi: 10.1016/j.atherosclerosis.2017.04.004. Epub 2017 Apr 11.
8
MiR-127-3p enhances macrophagic proliferation via disturbing fatty acid profiles and oxidative phosphorylation in atherosclerosis.miR-127-3p 通过扰乱动脉粥样硬化中的脂肪酸谱和氧化磷酸化来增强巨噬细胞增殖。
J Mol Cell Cardiol. 2024 Aug;193:36-52. doi: 10.1016/j.yjmcc.2024.05.010. Epub 2024 May 23.
9
Atorvastatin Blocks Advanced Glycation End Products Induced Reduction in Macrophage Cholesterol Efflux Mediated With ATP-Binding Cassette Transporters G 1.阿托伐他汀可阻断晚期糖基化终产物诱导的通过三磷酸腺苷结合盒转运体 G1 介导的巨噬细胞胆固醇外流减少。
Circ J. 2019 Aug 23;83(9):1954-1964. doi: 10.1253/circj.CJ-19-0153. Epub 2019 Aug 2.
10
Suppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of Apoe-/- mice during disease regression.在动脉粥样硬化斑块消退期间,受抑制的单核细胞募集导致 Apoe-/- 小鼠的巨噬细胞从斑块中被清除。
J Clin Invest. 2011 May;121(5):2025-36. doi: 10.1172/JCI43802. Epub 2011 Apr 18.

引用本文的文献

1
Mitigating atherosclerosis: Integrating vaccines with gene targets.减轻动脉粥样硬化:将疫苗与基因靶点相结合。
Am Heart J Plus. 2025 Aug 6;57:100588. doi: 10.1016/j.ahjo.2025.100588. eCollection 2025 Sep.
2
Aggressive Cholesterol Lowering Normalizes Atherosclerosis Regression in Clonal Hematopoiesis.积极降低胆固醇可使克隆性造血中的动脉粥样硬化消退正常化。
bioRxiv. 2025 Jul 30:2025.07.23.666334. doi: 10.1101/2025.07.23.666334.
3
The role of M1/M2 macrophage polarization in the pathogenesis of obesity-related kidney disease and related pathologies.

本文引用的文献

1
Local M-CSF (Macrophage Colony-Stimulating Factor) Expression Regulates Macrophage Proliferation and Apoptosis in Atherosclerosis.局部 M-CSF(巨噬细胞集落刺激因子)表达调节动脉粥样硬化中的巨噬细胞增殖和凋亡。
Arterioscler Thromb Vasc Biol. 2021 Jan;41(1):220-233. doi: 10.1161/ATVBAHA.120.315255. Epub 2020 Oct 22.
2
Microanatomy of the Human Atherosclerotic Plaque by Single-Cell Transcriptomics.单细胞转录组学解析人动脉粥样硬化斑块的微观解剖结构。
Circ Res. 2020 Nov 6;127(11):1437-1455. doi: 10.1161/CIRCRESAHA.120.316770. Epub 2020 Sep 28.
3
Ontogeny of arterial macrophages defines their functions in homeostasis and inflammation.
M1/M2巨噬细胞极化在肥胖相关肾病及相关病理发病机制中的作用。
Front Immunol. 2025 Jan 10;15:1534823. doi: 10.3389/fimmu.2024.1534823. eCollection 2024.
4
Anti-Inflammatory Oxysterol, Oxy210, Inhibits Atherosclerosis in Hyperlipidemic Mice and Inflammatory Responses of Vascular Cells.抗炎氧化固醇 Oxy210 抑制高脂血症小鼠动脉粥样硬化和血管细胞炎症反应。
Cells. 2024 Sep 30;13(19):1632. doi: 10.3390/cells13191632.
5
Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets.心血管疾病中的巨噬细胞:分子机制与治疗靶点。
Signal Transduct Target Ther. 2024 May 31;9(1):130. doi: 10.1038/s41392-024-01840-1.
6
ATP5O Hypo-crotonylation Caused by HDAC2 Hyper-Phosphorylation Is a Primary Detrimental Factor for Downregulated Phospholipid Metabolism under Chronic Stress.由HDAC2过度磷酸化导致的ATP5O低巴豆酰化是慢性应激下磷脂代谢下调的主要有害因素。
Research (Wash D C). 2022 Nov 24;2022:9834963. doi: 10.34133/2022/9834963. eCollection 2022.
7
Immune Homeostasis Maintenance Through Advanced Immune Therapeutics to Target Atherosclerosis.通过先进的免疫治疗靶向动脉粥样硬化来维持免疫稳态。
Methods Mol Biol. 2024;2782:25-37. doi: 10.1007/978-1-0716-3754-8_2.
8
Clonal Expansion in Cardiovascular Pathology.心血管病理学中的克隆性扩增
JACC Basic Transl Sci. 2023 Jul 19;9(1):120-144. doi: 10.1016/j.jacbts.2023.04.008. eCollection 2024 Jan.
9
Nonpreferential but Detrimental Accumulation of Macrophages With Clonal Hematopoiesis-Driver Mutations in Cardiovascular Tissues-Brief Report.心血管组织中具有克隆性造血驱动突变的巨噬细胞非优先但有害的积累——简要报告。
Arterioscler Thromb Vasc Biol. 2024 Mar;44(3):690-697. doi: 10.1161/ATVBAHA.123.320183. Epub 2024 Jan 25.
10
In Vitro Targeted Delivery of Simvastatin and Niacin to Macrophages Using Mannan-Grafted Magnetite Nanoparticles.使用甘露聚糖接枝的磁铁矿纳米颗粒将辛伐他汀和烟酸体外靶向递送至巨噬细胞
ACS Omega. 2023 Dec 18;9(1):658-674. doi: 10.1021/acsomega.3c06389. eCollection 2024 Jan 9.
动脉巨噬细胞的个体发生决定了它们在稳态和炎症中的功能。
Nat Commun. 2020 Sep 11;11(1):4549. doi: 10.1038/s41467-020-18287-x.
4
Limited proliferation capacity of aortic intima resident macrophages requires monocyte recruitment for atherosclerotic plaque progression.主动脉内膜驻留巨噬细胞的增殖能力有限,需要单核细胞募集来促进动脉粥样硬化斑块的进展。
Nat Immunol. 2020 Oct;21(10):1194-1204. doi: 10.1038/s41590-020-0768-4. Epub 2020 Sep 7.
5
Colchicine in Patients with Chronic Coronary Disease.秋水仙碱治疗慢性冠心病
N Engl J Med. 2020 Nov 5;383(19):1838-1847. doi: 10.1056/NEJMoa2021372. Epub 2020 Aug 31.
6
Meta-Analysis of Leukocyte Diversity in Atherosclerotic Mouse Aortas.动脉粥样硬化小鼠主动脉中白细胞多样性的荟萃分析。
Circ Res. 2020 Jul 17;127(3):402-426. doi: 10.1161/CIRCRESAHA.120.316903. Epub 2020 Jul 16.
7
Regulatory T Cells License Macrophage Pro-Resolving Functions During Atherosclerosis Regression.调节性 T 细胞在动脉粥样硬化消退过程中许可巨噬细胞发挥促修复功能。
Circ Res. 2020 Jul 17;127(3):335-353. doi: 10.1161/CIRCRESAHA.119.316461. Epub 2020 Apr 27.
8
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.心梗后小剂量秋水仙碱的疗效和安全性。
N Engl J Med. 2019 Dec 26;381(26):2497-2505. doi: 10.1056/NEJMoa1912388. Epub 2019 Nov 16.
9
Rapamycin-Loaded Biomimetic Nanoparticles Reverse Vascular Inflammation.载雷帕霉素仿生纳米颗粒逆转血管炎症。
Circ Res. 2020 Jan 3;126(1):25-37. doi: 10.1161/CIRCRESAHA.119.315185. Epub 2019 Oct 24.
10
Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review.载脂蛋白 B 颗粒与心血管疾病:一篇叙述性综述。
JAMA Cardiol. 2019 Dec 1;4(12):1287-1295. doi: 10.1001/jamacardio.2019.3780.